• Proceedings of the Korean Society of Life Science Conference
• /
• 2008.10a
• /
• pp.98.1-98.1
• /
• 2008

• Proceedings of the Korean Society of Precision Engineering Conference
• /
• 2002.10a
• /
• pp.792-795
• /
• 2002

In previous researches, it is reported that Ti-10Ta-10Nb is robuster than Ti-6A1-4V which is used as a biomaterial in a experiment of cytotoxicity. Ti-10Ta-10Nb has enough hardness to be required as a biomaterial because the change of its hardness can be controlled more than 100% according to heat treatment condition and manufacturing condition. There are many hardness changing condition including Cast Homogenization, Solution treatment. Forging, Rolling in this research. The changing form and amount of new Ti-10Ta-10Nb to be developed in this researches, are measured as quantitative. Specially, the changing hardness amount of the specimen that is manufactured in single phase temperature, i.e. 80$0^{\circ}C$, are measured in case of high temperature rolling and high temperature cast condition.

• Proceedings of the Korean Society of Crop Science Conference
• /
• 2007.11a
• /
• pp.31-31
• /
• 2007

• Journal of Applied Biological Chemistry
• /
• v.65 no.4
• /
• pp.447-451
• /
• 2022

Phytoestrogenic S-equol production in human gut exclusively depends on the biotransformation of daidzein to dihydrodaidzein (DHD). With a growing demand for the DHD enriched biomaterials, the commercial soybean hypocotyl extract (SHE) was chosen as a substrate for the microbial DHD production by human gut bacterium MRG-1, anaerobic DHD producer. To optimize the production of DHD, anaerobic fermentation conditions, including sterilization time, growth stage of inoculum, and growth media, were investigated. Maximum DHD production (1.2 g/L) was achieved after 48 h incubation when 1% (w/v) of SHE in the 20-min-sterilized Gifu Anaeboic Medium media was inoculated with OD₆₀₀ 0.3-0.4 of MRG-1. This is the first report that crude soy biomaterial, instead of pure compounds, such as daidzin and daidzein, is utilized for the production of the DHD enriched biomaterial.

• Journal of Life Science
• /
• v.17 no.2 s.82
• /
• pp.211-217
• /
• 2007

The goal of this study is to investigate effects of temperature and co-chaperonin requirement for in vitro protein refolding assisted by E. coli chaperone GroEL under permissive and nonpermissive temperature conditions. In vitro protein refolding of two denatured proteins was kinetically investigated under several conditions in the presence of GroEL. Effects of temperature and GroES-requirement on the process of prevention of protein aggregation and refolding of denatured protein were extensively monitored. We have found that E. coli GroEL chaperone system along with ATP is required for invitro refolding of unfolded polypeptide under nonpermissive temperature of $37^{\circ}C$. However, under permissive condition spontaneous refolding can occur due to lower temperature, which can competes with chaperone-mediated protein refolding via GroEL chaperone system. Thus, GroEL seemed to divert spontaneous refolding pathway of unfolded polypeptide toward chaperone-assisted refolding pathway, which is more efficient protein refolding pathway.

• The Journal of the Korean dental association
• /
• v.36 no.4 s.347
• /
• pp.289-295
• /
• 1998

Toothash and Plaster of Paris(Calcium sulfate) mixture have been studied for development of new biomaterial since 1992. I have performed the experimental and clinical study for evaluation of biocompatibility and possibility of bony defect reconstruction and clinical application. These materials are biocompatible, osteoconductive and resorbable. Main component of toothash is hydroxylapatite. In the future, I will perform the systematic construction of material and additional research.

• Bulletin of the Korean Chemical Society
• /
• v.35 no.12
• /
• pp.3661-3664
• /
• 2014

• Proceedings of the Korean Society of Life Science Conference
• /
• 2006.09a
• /
• pp.38.1-38.1
• /
• 2006

• Proceedings of the Korean Society of Life Science Conference
• /
• 2007.10a
• /
• pp.59.2-59.2
• /
• 2007

See Full Text

• Proceedings of the Korean Society of Life Science Conference
• /
• 2007.10a
• /
• pp.43.2-43.2
• /
• 2007

See Full Text